Clinical Trials Directory

Trials / Completed

CompletedNCT05722860

L-Citrulline and Endothelial Function

Effect of Oral L-Citrulline on the Peripheral and Central Endothelial Function in Young and Older Adults

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University of Oklahoma · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

The effect of L-Citrulline is well studied in relation to muscle strength, exhaustion, exercise performance, and endothelial function in health and disease. This study will extend current body of knowledge and will investigate the effect of L-Citrulline on brain vascular function.

Detailed description

Endothelial function is associated with nitric oxide (NO) availability for vasodilation, blood pressure and blood flow regulation, and vascular health. A large body of evidence demonstrates that aging is associated with a decrease in bioavailability of NO, with more pronounced decrease in sedentary individuals. NO can be produced via the NO synthase (NOS) enzymes, which catalyze the conversion of L-Arginine - a semi-essential amino acid found in fish, nuts and legumes amongst others - to L-Citrulline and produce NO as an endproduct. While the effect of L-Citrulline is extensively studied in relation to muscle strength, exhaustion, exercise performance, as well as on endothelial function in healthy and diseased individuals (including obese and those with heart failure), the effect of L-Citrulline on brain vascular function is not well studied.

Conditions

Interventions

TypeNameDescription
DRUGL-Citrulline, capsule5g/daily dose for the duration of 1 week intervention

Timeline

Start date
2024-01-03
Primary completion
2024-11-28
Completion
2024-12-28
First posted
2023-02-10
Last updated
2026-03-12

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05722860. Inclusion in this directory is not an endorsement.